Economic Considerations in Alzheimer's Disease

Alzheimer's disease (AD) is the third most expensive disease in the United States, costing society approximately $100 billion each year. It is one of the most prevalent illnesses in the elderly population, and with the aging of society, will become even more significant. Costs associated with AD include direct medical costs such as nursing home care, direct nonmedical costs such as in‐home day care, and indirect costs such as lost patient and caregiver productivity. Medical treatment may have economic benefits by slowing the rate of cognitive decline, delaying institutionalization, reducing caregiver hours, and improving quality of life. Pharmacoeconomic evaluations have shown positive results regarding the effect of drug therapy on nursing home placement, cognition, and caregiver time.

[1]  R. Ernst,et al.  The US economic and social costs of Alzheimer's disease revisited. , 1994, American journal of public health.

[2]  Hu Tw,et al.  The economic cost of senile dementia in the United States, 1985. , 1988 .

[3]  W W Hauck,et al.  The economic burden of Alzheimer's disease care. , 1993, Health affairs.

[4]  B. Chenoweth,et al.  Dementia: the experience of family caregivers. , 1986, The Gerontologist.

[5]  P. Gorelick,et al.  Psychotropic Drug Use in Relation to Psychiatric Symptoms in Community‐Living Persons With Alzheimer's Disease , 1995, Pharmacotherapy.

[6]  T. Hu,et al.  Evaluation of the costs of caring for the senile demented elderly: a pilot study. , 1986, The Gerontologist.

[7]  M. Burchmore,et al.  The economic impact of the tacrine in the treatment of Alzheimer's disease. , 1997, Clinical therapeutics.

[8]  E. Clipp,et al.  Caregiver time use: An outcome measure in clinical trial research on Alzheimer's disease , 1995, Clinical pharmacology and therapeutics.

[9]  T. Hu,et al.  The economic cost of senile dementia in the United States, 1985. , 1988, Public health reports.

[10]  B. Given,et al.  The costs of family contributions to the care of persons with dementia. , 1994, The Gerontologist.

[11]  D. Evans,et al.  Estimated prevalence of Alzheimer's disease in the United States. , 1990, The Milbank quarterly.

[12]  P V Rabins,et al.  The impact of dementia on the family. , 1982, JAMA.

[13]  M. Albert,et al.  Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported. , 1989, JAMA.

[14]  H. Welch,et al.  The Cost of Institutional Care in Alzheimer's Disease: Nursing Home and Hospital Use in a Prospective Cohort , 1992, Journal of the American Geriatrics Society.